Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

Vaccination with priming and expansion of tumour reacting T cells is an important therapeutic option to be used in combination with novel checkpoint inhibitors to increase the specificity of the T cell infiltrate and the efficacy of the treatment. In this phase I/II study, 14 high-risk disease-free...

Descripción completa

Detalles Bibliográficos
Autores principales: ANTONILLI, MORENA, RAHIMI, HASSAN, VISCONTI, VALERIA, NAPOLETANO, CHIARA, RUSCITO, ILARY, ZIZZARI, ILARIA GRAZIA, CAPONNETTO, SALVATORE, BARCHIESI, GIACOMO, IADAROLA, ROBERTA, PIERELLI, LUCA, RUGHETTI, AURELIA, BELLATI, FILIPPO, PANICI, PIERLUIGI BENEDETTI, NUTI, MARIANNA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777599/
https://www.ncbi.nlm.nih.gov/pubmed/26892612
http://dx.doi.org/10.3892/ijo.2016.3386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4777599/
https://www.ncbi.nlm.nih.gov/pubmed/26892612
http://dx.doi.org/10.3892/ijo.2016.3386

Ejemplares similares